← Back to Search

Other

Mobile Health Technology for Sickle Cell Disease

N/A

Waitlist Available

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between 18-70 years

Diagnosis of SCD (Hgb SS, SC, Sβ-thal)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will test whether a mobile phone technology intervention can improve disease-specific knowledge in people with SCD.

Who is the study for?

This trial is for adults aged 18-70 with Sickle Cell Disease (SCD) who get care at a community health clinic, can speak and understand English, and have access to a smartphone or computer. It's not for those without this technology or who don't understand English.Check my eligibility

What is being tested?

The study tests whether a mobile health application can improve healthcare in people with SCD by increasing their disease-specific knowledge. The app provides patient-centered guidelines and educational materials on smartphones.See study design

What are the potential side effects?

Since the intervention involves using an educational mobile app, there are no direct medical side effects like you'd expect from medication. However, users may experience stress or frustration if they encounter technical issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 70 years old.

Select...

I have been diagnosed with sickle cell disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

SCD-specific knowledge

Secondary outcome measures

Healthcare utilization (ER visits and hospitalizations)

Patient Activation

Self-efficacy

+1 more

Trial Design

2Treatment groups

Active Control

Group I: Control group (Booklets)Active Control1 Intervention

Group 1 will receive the control arm with a paper booklet of the patient-centered SCD-guidelines with education by a health care provider at a single visit

Group II: mobile health applicationActive Control1 Intervention

Group 2 will receive continuous access to technology-based patient-centered SCD-specific guidelines using a user-driven technological platform, plus a paper booklet of the guidelines with education by a health care provider at a single visit. The mobile app will include interactive content and a fully searchable collection of the SCD-specific guidelines that are age- and health literacy-appropriate. Through the mobile app, the investigators will reinforce important points of guideline content; motivate patient engagement through quizzes and reminders; and facilitate peer support, for instance by forming teams to compete against each other to attain goals.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

672,142 Total Patients Enrolled

Ohio State UniversityOTHER

828 Previous Clinical Trials

505,701 Total Patients Enrolled

Media Library

Mobile Health Application (Other) Clinical Trial Eligibility Overview. Trial Name: NCT03629678 — N/A

Sickle Cell Disease Research Study Groups: Control group (Booklets), mobile health application

Sickle Cell Disease Clinical Trial 2023: Mobile Health Application Highlights & Side Effects. Trial Name: NCT03629678 — N/A

Mobile Health Application (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03629678 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is my profile adequate to enroll in this investigation?

"The trial administrators are seeking 50 individuals exhibiting anemia and sickle cell disease, aged between 18-70. The prerequisites for enrollment necessitate that the patient receives care at a community health clinic, is diagnosed with SCD (Hgb SS, SC or Sβ-thal), comprehends English verbally and writtenly, has access to either a smartphone or computer device."

Answered by AI

Are any new participants welcomed to join this research endeavor?

"The information on clinicaltrials.gov does not indicate that this trial is presently accepting patients. The research was first posted in July 2018, and the latest update occurred November 2022; however, there are 198 other studies currently advertising for participants."

Answered by AI

Does this clinical trial accept participants younger than sixty years of age?

"The study's criteria necessitates that the enrollees are between 18 to 70 years of age. Moreover, 131 trials have been created specifically targeting minors and 86 studies for seniors."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease

Robert M Cronin, MD, MS 2018. "Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03629678.

All > Sickle Cell Disease > Sickle Cell Anemia